Study finds three times the risk of respiratory distress in infants born to COVID-infected mothers

New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves were not infected with the virus.

UK biotech revives former Kyowa Kirin cancer drug for Epstein-Barr-driven diseases

Hornet Therapeutics is on a mission to prevent and treat conditions related to the Epstein-Barr virus (EBV) with the help of a drug candidate shelved

May 24, 2024

Spexis is Granted Debt-Restructuring Moratorium – Biotech Investments

Spexis AG / Key word(s): Miscellaneous 05-Dec-2023 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely

December 6, 2023

Lutris wins FDA orphan drug tag for EGFR inhibitor-induced rash candidate – Pharmaceutical Technology

Share this article According to Lutris’ CEO, approximately 75% of cancer patients taking EGFR inhibitors develop some form of acneiform rash. Credit: sruilk via Getty

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.